Middle East respiratory syndrome: An emerging coronavirus infection tracked by the crowd

Virus Research

Volumn 202, Issue , 2015, Pages 60-88

  Mackay, Ian M ^a   Arden, Katherine E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Camel; Emerging infectious disease; Healthcare worker; MERS; MERS CoV; Zoonosis

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; AFRICA; ARTICLE; BAT; CELL CULTURE; CELL DAMAGE; COMORBIDITY; CORONAVIRUS INFECTION; COUGHING; DROMEDARY; DYSPNEA; EPIDEMIC; FEVER; FLU LIKE SYNDROME; GENETIC VARIABILITY; HEALTH CARE PERSONNEL; HUMAN; IMMUNOBIOLOGY; INFECTION PREVENTION; JORDAN; LOWER RESPIRATORY TRACT; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; MULTIPLE ORGAN FAILURE; NONHUMAN; PANDEMIC; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; SAUDI ARABIA; SEROLOGY; SEVERE ACUTE RESPIRATORY SYNDROME; TROPISM; VIRUS DETECTION; VIRUS GENOME; VIRUS SHEDDING; VIRUS SURVIVAL; VIRUS TRANSMISSION; ANIMAL; ASIA; CAMEL; COMMUNICABLE DISEASES, EMERGING; CORONAVIRUS INFECTIONS; ISOLATION AND PURIFICATION; PATHOLOGY; VIROLOGY; ZOONOSES;

CAMELIDAE; CAMELUS DROMEDARIUS; CORONAVIRUS; SARS CORONAVIRUS;

AFRICA; ANIMALS; ARABIA; CAMELS; CHIROPTERA; COMMUNICABLE DISEASES, EMERGING; CORONAVIRUS INFECTIONS; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; ZOONOSES;

EID: 84930040783     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2015.01.021     Document Type: Article

References (188)

1. ® N Effective Against MERS (Middle East Respiratory Syndrome) Virus In-Vitro 2014, http://www.hemispherx.net/content/investor/default.asp?goto=781.
2. Abdel-Moneim A.S. Middle East respiratory syndrome coronavirus (MERS-CoV): evidence and speculations. Arch. Virol. 2014, 159:1575-1584.
3. Aburizaiza A.S., Mattes F.M., Azhar E.I., Hassan A.M., Memish Z.A., Muth D., Meyer B., Lattwein E., Muller M.A., Drosten C. Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. J. Infect. Dis. 2014, 209:243-246.
4. Adney D.R., van D.N., Brown V.R., Bushmaker T., Scott D., de W.E., Bowen R.A., Munster V.J. Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels. Emerg. Infect. Dis. 2014, 20:1999-2005.
5. Agnihothram S., Yount B.L., Donaldson E.F., Huynh J., Menachery V.D., Gralinski L.E., Graham R.L., Becker M.M., Tomar S., Scobey T.D., Osswald H.L., Whitmore A., Gopal R., Ghosh A.K., Mesecar A., Zambon M., Heise M., Denison M.R., Baric R.S. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant. MBio. 2014, 5. e00047-14.
6. Agrawal A.S., Garron T., Tao X., Peng B.H., Wakamiya M., Chan T.S., Couch R.B., Tseng C.T. Generation of transgenic mouse model of middle east respiratory syndrome-coronavirus infection and disease. J. Virol. 2015.
7. Agrawal R.P., Dogra R., Mohta N., Tiwari R., Singhal S., Sultania S. Beneficial effect of camel milk in diabetic nephropathy. Acta Biomed. 2009, 80:131-134.
8. Al-Abdallat M.M., Payne D.C., Alqasrawi S., Rha B., Tohme R.A., Abedi G.R., Al N.M., Iblan I., Jarour N., Farag N.H., Haddadin A., Al-Sanouri T., Tamin A., Harcourt J.L., Kuhar D.T., Swerdlow D.L., Erdman D.D., Pallansch M.A., Haynes L.M., Gerber S.I. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin. Infect. Dis. 2014.
9. Al-Gethamy M., Corman V.M., Hussain R., Al-Tawfiq J.A., Drosten C., Memish Z.A. A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker. Clin. Infect. Dis. 2014.
10. Al-Tawfiq J.A., Memish Z.A. Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolution. Trends Microbiol. 2014, 22:573-579.
11. Al-Tawfiq J.A., Momattin H., Dib J., Memish Z.A. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int. J. Infect. Dis. 2014, 20:42-46.
12. Al-Yousef N., Gaafar A., Al-Otaibi B., Al-Jammaz I., Al-Hussein K., Aboussekhra A. Camel urine components display anti-cancer properties in vitro. J. Ethnopharmacol. 2012, 143:819-825.
13. Alagaili A.N., Briese T., Mishra N., Kapoor V., Sameroff S.C., Burbelo P.D., de W.E., Munster V.J., Hensley L.E., Zalmout I.S., Kapoor A., Epstein J.H., Karesh W.B., Daszak P., Mohammed O.B., Lipkin W.I. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio. 2014, 5:e00884-e914.
14. Albarrak A.M., Stephens G.M., Hewson R., Memish Z.A. Recovery from severe novel coronavirus infection. Saudi Med. J. 2012, 33:1265-1269.
15. Alexandersen S., Kobinger G.P., Soule G., Wernery U. Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005. Transbound. Emerg. Dis. 2014, 61:105-108.
16. Alhaidar A., bdel Gader A.G., Mousa S.A. The antiplatelet activity of camel urine. J. Altern. Complement. Med. 2011, 17:803-808.
17. Almazán F., DeDiego M.L., Sola I., Zuniga S., Nieto-Torres J.L., Marquez-Jurado S., Andres G., Enjuanes L. Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. MBio. 2013, 4:e00650-e00713.
18. Arabi Y.M., Arifi A.A., Balkhy H.H., Najm H., Aldawood A.S., Ghabashi A., Hawa H., Alothman A., Khaldi A., Al Raiy B. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann. Intern. Med. 2014, 160:389-397.
19. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A., Al-Rabiah F.A., Al-Hajjar S., Al-Barrak A., Flemban H., Al-nassir W.N., Balkhy H.H., Al-Hakeem R.F., Makhdoom H.Q., Zumla A.I., Memish Z.A. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 2013, 13:752-761.
20. Assiri A., McGeer A., Perl T.M., Price C.S., Al Rabeeah A.A., Cummings D.A., Alabdullatif Z.N., Assad M., Almulhim A., Makhdoom H., Madani H., Alhakeem R., Al-Tawfiq J.A., Cotten M., Watson S.J., Kellam P., Zumla A.I., Memish Z.A. Hospital outbreak of Middle East respiratory syndrome coronavirus. N. Engl. J. Med. 2013, 369:407-416.
21. Azhar E.I., El-Kafrawy S.A., Farraj S.A., Hassan A.M., Al-Saeed M.S., Hashem A.M., Madani T.A. Evidence for camel-to-human transmission of MERS coronavirus. N. Engl. J. Med. 2014.
22. Azhar E.I., Hashem A.M., El-Kafrawy S.A., Sohrab S.S., Aburizaiza A.S., Farraj S.A., Hassan A.M., Al-Saeed M.S., Jamjoom G.A., Madani T.A. Detection of the Middle East respiratory syndrome coronavirus genome in an air sample originating from a camel barn owned by an infected patient. MBio. 2014, 5:e01450-e1514.
23. Barasheed O., Rashid H., Alfelali M., Tashani M., Azeem M., Bokhary H., Kalantan N., Samkari J., Heron L., Kok J., Taylor J., El B.H., Memish Z.A., Haworth E., Holmes E.C., Dwyer D.E., Asghar A., Booy R. Viral respiratory infections among Hajj pilgrims in 2013. Virol. Sin. 2014, 29:364-371.
24. Barlan A., Zhao J., Sarkar M.K., Kun L., McCray P.B., Perlman S., Gallagher T. Receptor variation and susceptibility to Middle East respiratoy syndrome coronavirus infection. J Virol. 2014.
25. Bauch C.T., Oraby T. Assessing the pandemic potential of MERS-CoV. Lancet 2013, 382:662-664.
26. Bermingham A., Chand M.A., Brown C.S., Aarons E., Tong C., Langrish C., Hoschler K., Brown K., Galiano M., Myers R., Pebody R.G., Green H.K., Boddington N.L., Gopal R., Price N., Newsholme W., Drosten C., Fouchier R.A., Zambon M. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill. 2012, 17:20290.
27. Bialek S.R., Allen D., varado-Ramy F., Arthur R., Balajee A., Bell D., Best S., Blackmore C., Breakwell L., Cannons A., Brown C., Cetron M., Chea N., Chommanard C., Cohen N., Conover C., Crespo A., Creviston J., Curns A.T., Dahl R., Dearth S., DeMaria A., Echols F., Erdman D.D., Feikin D., Frias M., Gerber S.I., Gulati R., Hale C., Haynes L.M., Heberlein-Larson L., Holton K., Ijaz K., Kapoor M., Kohl K., Kuhar D.T., Kumar A.M., Kundich M., Lippold S., Liu L., Lovchik J.C., Madoff L., Martell S., Matthews S., Moore J., Murray L.R., Onofrey S., Pallansch M.A., Pesik N., Pham H., Pillai S., Pontones P., Pringle K., Pritchard S., Rasmussen S., Richards S., Sandoval M., Schneider E., Schuchat A., Sheedy K., Sherin K., Swerdlow D.L., Tappero J.W., Vernon M.O., Watkins S., Watson J. First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb. Mortal. Wkly. Rep. 2014, 63:431-436.
28. Boonacker E., Van Noorden C.J. The multifunctional or moonlighting protein CD26/DPPIV. Eur. J. Cell Biol. 2003, 82:53-73.
29. Breban R., Riou J., Fontanet A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 2013, 382:694-699.
30. Brown C. Call for infection control to stem MERS. CMAJ 2014.
31. CDC Telebriefing - Updates on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Investigation in the United States 2014, http://www.cdc.gov/media/releases/2014/t0517-mers.html.
32. Cauchemez S., Fraser C., Van K., Donnelly C.A., Riley S., Rambaut A., Enouf V., van der W.S., Ferguson N.M. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect. Dis. 2014, 14:50-56.
33. CDC Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Patients Under Investigation (PUIs) for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - Version 2. 7-6-2014 2014, http://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html.
34. CDC Newsroom CDC Concludes Indiana MERS Patient did not Spread Virus to Illinois Business Associate. 28-5-2014 2014, http://www.cdc.gov/media/releases/2014/p0528-mers.html.
35. Chan J.F., Chan K.H., Choi G.K., To K.K., Tse H., Cai J.P., Yeung M.L., Cheng V.C., Chen H., Che X.Y., Lau S.K., Woo P.C., Yuen K.Y. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J. Infect. Dis. 2013, 207:1743-1752.
36. Chan K.H., Chan J.F., Tse H., Chen H., Lau C.C., Cai J.P., Tsang A.K., Xiao X., To K.K., Lau S.K., Woo P.C., Zheng B.J., Wang M., Yuen K.Y. Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests. J. Infect. 2013, 67:130-140.
37. Chan K.H., Peiris J.S., Lam S.Y., Poon L.L., Yuen K.Y., Seto W.H. The effects of temperature and relative humidity on the viability of the SARS coronavirus. Adv. Virol. 2011, 2011:734690.
38. Chan R.W., Chan M.C., Agnihothram S., Chan L.L., Kuok D.I., Fong J.H., Guan Y., Poon L.L., Baric R.S., Nicholls J.M., Peiris J.S. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J. Virol. 2013, 87:6604-6614.
39. Chen Y., Rajashankar K.R., Yang Y., Agnihothram S.S., Liu C., Lin Y.-L., Baric R.S., Li F. Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus. J. Virol. 2013, 87:10777-10783.
40. Chowell G., Blumberg S., Simonsen L., Miller M.A., Viboud C. Synthesizing data and models for the spread of MERS-CoV, 2013: key role of index cases and hospital transmission. Epidemics 2014, 9:40-51.
41. Chu D.K.W., Poon L.L.M., Gomaa M.R., Shehata M.M., Perera R.A.P.M., Zeid D.A., El Rifay A.S., Siu L.Y., Guan Y., Webby R.J., Ali M.A., Peiris M., Kayali G. MERS coronaviruses in dromedary camels, Egypt. Emerg. Infect. Dis. 2014, 20.
42. Chu K.H., Tsang W.K., Tang C.S., Lam M.F., Lai F.M., To K.F., Fung K.S., Tang H.L., Yan W.W., Chan H.W., Lai T.S., Tong K.L., Lai K.N. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int. 2005, 67:698-705.
43. Coleman C.M., Liu Y.V., Mu H., Taylor J.K., Massare M., Flyer D.C., Smith G.E., Frieman M.B. Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine 2014.
44. Coleman C.M., Matthews K.L., Goicochea L., Frieman M.B. Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus. J. Gen. Virol. 2014, 95:408-412.
45. Corman V.M., Eckerle I., Bleicker T., Zaki A., Landt O., Eschbach-Bludau M., van B.S., Gopal R., Ballhause M., Bestebroer T.M., Muth D., Muller M.A., Drexler J.F., Zambon M., Osterhaus A.D., Fouchier R.M., Drosten C. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012, 17.
46. Corman V.M., Ithete N.L., Richards L.R., Schoeman M.C., Preiser W., Drosten C., Drexler J.F. Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat. J. Virol. 2014, 88:11297-11303.
47. Corman V.M., Jores J., Meyer B., Younan M., Liljander A., Said M.Y., Gluecks I., Lattwein E., Bosch B.J., Drexler J.F., Bornstein S., Drosten C., Muller M.A. Antibodies against MERS Coronavirus in Dromedary Camels, Kenya, 1992-2013. Emerg. Infect. Dis. 2014, 20.
48. Corman V.M., Muller M.A., Costabel U., Timm J., Binger T., Meyer B., Kreher P., Lattwein E., Eschbach-Bludau M., Nitsche A., Bleicker T., Landt O., Schweiger B., Drexler J.F., Osterhaus A.D., Haagmans B.L., Dittmer U., Bonin F., Wolff T., Drosten C. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012, 17.
49. Coston M. Avian Flu Diary: Michael Coston's Blog on Emerging Infectious Diseases 2014, http://afludiary.blogspot.com.au/.
50. Cotten M., Lam T.T., Watson S.J., Palser A.L., Petrova V., Grant P., Pybus O.G., Rambaut A., Guan Y., Pillay D., Kellam P., Nastouli E. Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus. Emerg. Infect. Dis. 2013, 19. 736-42B.
51. Cotten M., Watson S.J., Kellam P., Al-Rabeeah A.A., Makhdoom H.Q., Assiri A., Al-Tawfiq J.A., Alhakeem R.F., Madani H., AlRabiah F.A., Al H.S., Al-nassir W.N., Albarrak A., Flemban H., Balkhy H.H., Alsubaie S., Palser A.L., Gall A., Bashford-Rogers R., Rambaut A., Zumla A.I., Memish Z.A. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet 2013, 382:1993-2002.
52. Cotten M., Watson S.J., Zumla A.I., Makhdoom H.Q., Palser A.L., Ong S.H., Al Rabeeah A.A., Alhakeem R.F., Assiri A., Al-Tawfiq J.A., Albarrak A., Barry M., Shibl A., AlRabiah F.A., Hajjar S., Balkhy H.H., Flemban H., Rambaut A., Kellam P., Memish Z.A. Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. MBio. 2014, 5.
53. Deadly MERS Virus Circulates Among Arabian Camels 2014, http://www.npr.org/blogs/health/2014/02/25/282136478/deadly-mers-virus-circulates-among-arabian-camels.
54. de Groot R.J., Baker S.C., Baric R.S., Brown C.S., Drosten C., Enjuanes L., Fouchier R.A., Galiano M., Gorbalenya A.E., Memish Z.A., Perlman S., Poon L.L., Snijder E.J., Stephens G.M., Woo P.C., Zaki A.M., Zambon M., Ziebuhr J. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J. Virol. 2013, 87:7790-7792.
55. de Wilde A.H., Jochmans D., Posthuma C.C., Zevenhoven-Dobbe J.C., van N.S., Bestebroer T.M., van den Hoogen B.G., Neyts J., Snijder E.J. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob. Agents Chemother. 2014.
56. Devi J.P., Noraini W., Norhayati R., Kheong C.C., Badrul A.S., Zainah S., Fadzilah K., Hirman I., Hakim S.L., Hisham A.N. Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014. Eurosurveillance 2014, 19:20797.
57. deWit E., Rasmussen A.L., Falzarano D., Bushmaker T., Feldmann F., Brining D.L., Fischer E.R., Martellaro C., Okumura A., Chang J., Scott D., Benecke A.G., Katze M.G., Feldmann H., Munster V.J. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:16598-16603.
58. Drosten C. Is MERS another SARS?. Lancet Infect. Dis. 2013, 13:727-728.
59. Drosten C., Kellam P., Memish Z.A. Evidence for camel-to-human transmission of MERS coronavirus. N. Engl. J. Med. 2014, 371:1359-1360.
60. Drosten C., Meyer B., Muller M.A., Corman V.M., Al-Masri M., Hossain R., Madani H., Sieberg A., Bosch B.J., Lattwein E., Alhakeem R.F., Assiri A.M., Hajomar W., Albarrak A.M., Al-Tawfiq J.A., Zumla A.I., Memish Z.A. Transmission of MERS-coronavirus in household contacts. N. Engl. J. Med. 2014, 371:828-835.
61. Drosten C., Muth D., Corman V.M., Hussain R., al M.M., Hajomar W., Landt O., Assiri A., Eckerle I., Al S.A., Al-Tawfiq J.A., Albarrak A., Zumla A., Rambaut A., Memish Z.A. An observational, laboratory-based study of outbreaks of MERS-coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014. Clin. Infect. Dis. 2015, 60:369-377.
62. Drosten C., Seilmaier M., Corman V.M., Hartmann W., Scheible G., Sack S., Guggemos W., Kallies R., Muth D., Junglen S., Muller M.A., Haas W., Guberina H., Rohnisch T., Schmid-Wendtner M., Aldabbagh S., Dittmer U., Gold H., Graf P., Bonin F., Rambaut A., Wendtner C.M. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect. Dis. 2013, 13:745-751.
63. Du L., Kou Z., Ma C., Tao X., Wang L., Zhao G., Chen Y., Yu F., Tseng C.T., Zhou Y., Jiang S. A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines. PLOS ONE 2013, 8:e81587.
64. Du L., Zhao G., Kou Z., Ma C., Sun S., Poon V.K., Lu L., Wang L., Debnath A.K., Zheng B.J., Zhou Y., Jiang S. Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development. J. Virol. 2013, 87:9939-9942.
65. Dudley J.P., Mackay I.M. Age-specific and sex-specific morbidity and mortality from avian influenza A(H7N9). J. Clin. Virol. 2013, 58:568-570.
66. Dyall J., Coleman C.M., Hart B.J., Venkataraman T., Holbrook M.R., Kindrachuk J., Johnson R.F., Olinger G.G., Jahrling P.B., Laidlaw M., Johansen L.M., Lear C.M., Glass P.J., Hensley L.E., Frieman M.B. Repurposing of clinically developed drugs for treatment of Middle East Respiratory Coronavirus Infection. Antimicrob. Agents Chemother. 2014.
67. Eckerle I., Corman V.M., Muller M.A., Lenk M., Ulrich R.G., Drosten C. Replicative capacity of MERS coronavirus in livestock cell lines. Emerg. Infect. Dis. 2014, 20:276-279.
68. Eckerle I., Muller M.A., Kallies S., Gotthardt D.N., Drosten C. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection. Virol. J. 2013, 10:359.
69. Editorial MERS-CoV: address the knowledge gaps to move forward. Lancet 2014, 383:1782.
70. EUROIMMUN Medizinische Labordiagnostika AGf Test Characteristics: Anti-MERS-CoV ELISA Camel (IgG) 2014, http://www.vet.euroimmun.de/fileadmin/vet_euroimmun/pdf/EI_2604V_D_UK_A.pdf.
71. Falzarano D., de W.E., Rasmussen A.L., Feldmann F., Okumura A., Scott D.P., Brining D., Bushmaker T., Martellaro C., Baseler L., Benecke A.G., Katze M.G., Munster V.J., Feldmann H. Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat. Med. 2013, 19:1313-1317.
72. Faure E., Poissy J., Goffard A., Fournier C., Kipnis E., Titecat M., Bortolotti P., Martinez L., Dubucquoi S., Dessein R., Gosset P., Mathieu D., Guery B. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?. PLOS ONE 2014, 9:e88716.
73. Frey K.G., Redden C.L., Bishop-Lilly K.A., Johnson R., Hensley L.E., Raviprakash K., Luke T., Kochel T., Mokashi V.P., Defang G.N. Full-genome sequence of human betacoronavirus 2c jordan-n3/2012 after serial passage in Mammalian cells. Genome Announc. 2014, 2.
74. Gautret P., Charrel R., Belhouchat K., Drali T., Benkouiten S., Nougairede A., Zandotti C., Memish Z.A., al Masri M.M., Gaillard C., Brouqui P., Parola P. Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin. Microbiol. Infect. 2013, 19:E315-E317.
75. Gierer S., Hofmann-Winkler H., Albuali W.H., Bertram S., Al-Rubaish A.M., Yousef A.A., Al-Nafaie A.N., Al-Ali A.K., Obeid O.E., Alkharsah K.R., Pohlmann S. Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia. Emerg. Infect. Dis. 2013, 19:2034-2036.
76. Gossner C., Danielson N., Gervelmeyer A., Berthe F., Faye B., Kaasik A.K., Adlhoch C., Zeller H., Penttinen P., Coulombier D. Human-Dromedary camel interactions and the risk of acquiring zoonotic Middle East respiratory syndrome coronavirus infection. Zoonoses Public Health 2014.
77. Granger S. Random Analytics 2012, http://gmggranger.wordpress.com/.
78. Grouzmann E., Monod M., Landis B., Wilk S., Brakch N., Nicoucar K., Giger R., Malis D., Szalay-Quinodoz I., Cavadas C., Morel D.R., Lacroix J.S. Loss of dipeptidylpeptidase IV activity in chronic rhinosinusitis contributes to the neurogenic inflammation induced by substance P in the nasal mucosa. FASEB J. 2002, 16:1132-1134.
79. Gundy P.M., Gerba C.P., Pepper I.L. Survival of coronaviruses in water and wastewater. Food Environ. Virol. 2009, 1:10-14.
80. Haagmans B.L., Al Dhahiry S.H., Reusken C.B., Raj V.S., Galiano M., Myers R., Godeke G.J., Jonges M., Farag E., Diab A., Ghobashy H., Alhajri F., Al-Thani M., Al-Marri S.A., Al Romaihi H.E., Al K.A., Bermingham A., Osterhaus A.D., AlHajri M.M., Koopmans M.P. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect. Dis. 2014, 14:140-145.
81. Hartl G. Novel coronavirus: the challenge of communicating about a virus which one knows little about. East. Mediterr. Health J. 2013, 1(19 Suppl.):S26-S30.
82. Health Protection Agency (HPA) UK Novel Coronavirus Investigation Team Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Eurosurveillance 2013, 18:20427.
83. Hemida M.G., Al-Naeem A., Perera R.A.P.M., Chin A.W.H., Poon L.L.M., Peiris M. Lack of Middle East respiratory syndrome coronavirus transmission from infected camels. Emerg. Infect. Dis. 2015, 21.
84. Hemida M.G., Chu D.K.W., Poon L.L.M., Perera R.A.P.M., Alhammadi M.A., Ng H.-Y., Siu L.Y., Guan Y., Alnaeem A., Peiris M. MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg. Infect. Dis. 2014, 20.
85. Hemida M.G., Perera R.A., Al Jassim R.A., Kayali G., Siu L.Y., Wang P., Chu K.W., Perlman S., Ali M.A., Alnaeem A., Guan Y., Poon L.L., Saif L., Peiris M. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill. 2014, 19.
86. Hemida M.G., Perera R.A., Wang P., Alhammadi M.A., Siu L.Y., Li M., Poon L.L., Saif L., Alnaeem A., Peiris M. Middle East respiratory syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill. 2013, 18:20659.
87. Hijawi B., Abdallat M., Sayaydeh A., Alqasrawi S., Haddadin A., Jaarour N., Alsheikh S., Alsanouri T. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East. Mediterr. Health J. 2013, 1(19 Suppl.):S12-S18.
88. Holmes D. MERS-CoV enigma deepens as reported cases surge. Lancet 2014, 383:1793.
89. Jiang L., Wang N., Zuo T., Shi X., Poon K.M., Wu Y., Gao F., Li D., Wang R., Guo J., Fu L., Yuen K.Y., Zheng B.J., Wang X., Zhang L. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci. Transl. Med. 2014, 6. 234ra59.
90. Josset L., Menachery V.D., Gralinski L.E., Agnihothram S., Sova P., Carter V.S., Yount B.L., Graham R.L., Baric R.S., Katze M.G. Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. MBio. 2013, 4:e00165-e213.
91. Kawalec P., Mikrut A., Lopuch S. The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab. Res. Rev. 2014.
92. Khalid M., Al R.F., Khan B., Al M.A., Butt T.S., Al M.E. Ribavirin and interferon (IFN)-alpha-2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus (MERS-CoV): a preliminary report of two cases. Antivir. Ther. 2014.
93. Khuri-Bulos N., Payne D.C., Lu X., Erdman D., Wang L., Faouri S., Shehabi A., Johnson M., Becker M.M., Denison M.R., Williams J.V., Halasa N.B. Middle East respiratory syndrome coronavirus not detected in children hospitalized with acute respiratory illness in Amman, Jordan, March 2010 to September 2012. Clin. Microbiol. Infect. 2013.
94. Kilian C. H5N1: Crawford Kilian's Infectious Disease Blog. 8-6-2014 2014, http://crofsblogs.typepad.com/h5n1/.
95. Kilianski A., Mielech A.M., Deng X., Baker S.C. Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors. J. Virol. 2013, 87:11955-11962.
96. Kindler E., Jonsdottir H.R., Muth D., Hamming O.J., Hartmann R., Rodriguez R., Geffers R., Fouchier R.A., Drosten C., Muller M.A., Dijkman R., Thiel V. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio. 2013, 4:e00611-e00612.
97. Knibbs L.D., Johnson G.R., Kidd T.J., Cheney J., Grimwood K., Kattenbelt J.A., O'Rourke P.K., Ramsay K.A., Sly P.D., Wainwright C.E., Wood M.E., Morawska L., Bell S.C. Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis. Thorax 2014.
98. Kraaij-Dirkzwager M., Timen A., Dirksen K., Gelnick L., Leyten E., Groeneveld P. Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014. Euro Surveill. 2014, 19:20817.
99. Kupferschmidt K. The camel connection. Science 2014, 343(1422-3):1425.
100. Link Between MERS Virus and Camels Worries Breeders - 10-8-2014d 2014, http://www.arabnews.com/news/460814.
101. Lau E.H.Y., Zheng J., Tsang T.K., Liao Q., Lewis B., Brownstein J.S., Sanders S., Wong J.Y., Mekaru S.R., Rivers C., Wu P., Jiang H., Li Y., Yu J., Yu J., Zhang Q., Chang Z., Liu F., Peng Z., Leung G.M., Feng L., Cowling B.J., Yu H. Accuracy of epidemiological inferences based on publicly available information: retrospective comparative analysis of line lists of hman cases infected with inflenza A(H7N9) in China. BMC Med. 2014, 12.
102. Lau S.K., Lau C.C., Chan K.H., Li C.P., Chen H., Jin D.Y., Chan J.F., Woo P.C., Yuen K.Y. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J. Gen. Virol. 2013, 94:2679-2690.
103. Lin M.H., Chuang S.J., Chen C.C., Cheng S.C., Cheng K.W., Lin C.H., Sun C.Y., Chou C.Y. Structural and functional characterization of MERS coronavirus papain-like protease. J. Biomed. Sci. 2014, 21:54.
104. Lu G., Hu Y., Wang Q., Qi J., Gao F., Li Y., Zhang Y., Zhang W., Yuan Y., Bao J., Zhang B., Shi Y., Yan J., Gao G.F. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 2013, 500:227-231.
105. Lun S.W., Wong C.K., Ko F.W., Hui D.S., Lam C.W. Increased expression of plasma and CD4+ T lymphocyte costimulatory molecule CD26 in adult patients with allergic asthma. J. Clin. Immunol. 2007, 27:430-437.
106. Lundin A., Dijkman R., Bergstrom T., Kann N., Adamiak B., Hannoun C., Kindler E., Jonsdottir H.R., Muth D., Kint J., Forlenza M., Muller M.A., Drosten C., Thiel V., Trybala E. Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus. PLoS Pathog. 2014, 1004166.
107. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - Update 15-May-2014e 2014, http://www.who.int/csr/don/2014_05_15_mers/en/.
108. Mackay I.M. MERS-CoV Daily, Monthly and Cumulative Numbers Over Time. 1-12-0015 2014, http://virologydownunder.blogspot.com.au/2014/08/mers-cov-daily-monthly-and-cumulative.html.
109. Mackay I.M. Virology Down Under. 21-6-2014a 1997, http://www.uq.edu.au/vdu/.
110. Mackay I.M. Virology Down Under Blog. 2-6-2014b 2013, http://virologydownunder.blogspot.com.au/.
111. Mackay I.M., Arden K.E., Speicher D.J., O'Neill N.T., McErlean P.K., Greer R.M., Nissen M.D., Sloots T.P. Co-circulation of four human coronaviruses (HCoVs) in Queensland children with acute respiratory tract illnesses in 2004. Viruses 2012, 4:637-653.
112. Mailles A., Blanckaert K., Chaud P., van der W.S., Lina B., Caro V., Campese C., Guery B., Prouvost H., Lemaire X., Paty M.C., Haeghebaert S., Antoine D., Ettahar N., Noel H., Behillil S., Hendricx S., Manuguerra J.C., Enouf V., La R.G., Semaille C., Coignard B., Levy-Bruhl D., Weber F., Saura C., Che D. First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro Surveill. 2013, 18.
113. Majumder M. Mens et Manus: Maia Majumder's Blog. 8-6-2014 2014, http://maimunamajumder.wordpress.com/.
114. Maltezou H.C., Tsiodras S. Middle East respiratory syndrome coronavirus: Implications for health care facilities. Am. J. Infect. Control 2014, 42:1261-1265.
115. Memish Z.A., Al-Tawfiq J.A., Assiri A., AlRabiah F.A., Hajjar S.A., Albarrak A., Flemban H., Alhakeem R.F., Makhdoom H.Q., Alsubaie S., Al-Rabeeah A.A. Middle East Respiratory Syndrome Coronavirus Disease in Children. Pediatr. Infect. Dis. J. 2014.
116. Memish Z.A., Al-Tawfiq J.A., Makhdoom H.Q., Al-Rabeeah A.A., Assiri A., Alhakeem R.F., AlRabiah F.A., Al H.S., Albarrak A., Flemban H., Balkhy H., Barry M., Alhassan S., Alsubaie S., Zumla A. Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study. Clin. Microbiol. Infect. 2014.
117. Memish Z.A., Al-Tawfiq J.A., Makhdoom H.Q., Assiri A., Alhakeem R.F., Albarrak A., Alsubaie S., Al-Rabeeah A.A., Hajomar W.H., Hussain R., Kheyami A.M., Almutairi A., Azhar E.I., Drosten C., Watson S.J., Kellam P., Cotten M.W., Zumla A. Respiratory Tract Samples, Viral Load and Genome Fraction Yield in patients with Middle East Respiratory Syndrome. J. Infect. Dis. 2014.
118. Memish Z.A., Assiri A., Almasri M., Alhakeem R.F., Turkestani A., Al Rabeeah A.A., Al-Tawfiq J.A., Alzahrani A., Azhar E., Makhdoom H.Q., Hajomar W.H., Al-Shangiti A.M., Yezli S. Prevalence of MERS-CoV Nasal Carriage and Compliance With the Saudi Health Recommendations Among Pilgrims Attending the 2013 Hajj. J. Infect. Dis. 2014.
119. Memish Z.A., Assiri A.M., Al-Tawfiq J.A. Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational analysis with infection control implications. Int. J. Infect. Dis. 2014, 29:307-308.
120. Memish Z.A., Cotten M., Meyer B., Watson S.J., Alsahafi A.J., Al Rabeeh A.A., Corman V.M., Sieberg A., Makhdoom H.Q., Assiri A., Al Masri M., Aldabbagh S., Bosch R.J., Beer M., Müller M.A., Kellam P., Drosten C. Human Infection with MERS Coronavirus after Exposure to Infected Camels, Saudi Arabia, 2013. Emerg. Infect. Dis. 2014, 20.
121. Memish Z.A., Cotten M., Watson S.J., Kellam P., Zumla A., Alhakeem R.F., Assiri A., Rabeeah A.A., Al-Tawfiq J.A. Community Case Clusters of Middle East Respiratory Syndrome Coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: A Descriptive Genomic study. Int. J. Infect. Dis. 2014.
122. Memish Z.A., Mishra N., Olival K.J., Fagbo S.F., Kapoor V., Epstein J.H., Alhakeem R., Durosinloun A., Al A.M., Islam A., Kapoor A., Briese T., Daszak P., Al Rabeeah A.A., Lipkin W.I. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg. Infect. Dis. 2013, 19:1819-1823.
123. Memish Z.A., Zumla A.I., Al-Hakeem R.F., Al-Rabeeah A.A., Stephens G.M. Family cluster of Middle East respiratory syndrome coronavirus infections. N. Engl. J. Med. 2013, 368:2487-2494.
124. Meyer B., Drosten C., Muller M.A. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res. 2014.
125. Meyer B., Garcia-Bocanegra I., Wernery U., Wernery R., Sieberg A., Muller M.A., Drexler J.F., Drosten C., Eckerle I. Serologic Assessment of Possibility for MERS-CoV Infection in Equids. Emerg. Infect. Dis. 2015, 21:181-182.
126. Meyer B., Muller M.A., Corman V.M., Reusken C.B., Ritz D., Godeke G.J., Lattwein E., Kallies S., Siemens A., van B.J., Drexler J.F., Muth D., Bosch B.J., Wernery U., Koopmans M.P., Wernery R., Drosten C. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg. Infect. Dis. 2014, 20:552-559.
127. Ministry of Health, Saudi Arabia 2012-2014 Case List of MoH/WHO Novel Coronavirus MERS nCoV Announced Cases. 7-6-2014 2014, http://www.flutrackers.com/forum/showthread.php?t=205075.
128. Mohamad R.H., Zekry Z.K., Al-Mehdar H.A., Salama O., El-Shaieb S.E., El-Basmy A.A., Al-said M.G., Sharawy S.M. Camel milk as an adjuvant therapy for the treatment of type 1 diabetes: verification of a traditional ethnomedical practice. J. Med. Food 2009, 12:461-465.
129. Mou H., Raj V.S., van Kuppeveld F.J., Rottier P.J., Haagmans B.L., Bosch B.J. The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J. Virol. 2013, 87:9379-9383.
130. Muller M.A., Raj V.S., Muth D., Meyer B., Kallies S., Smits S.L., Wollny R., Bestebroer T.M., Specht S., Suliman T., Zimmermann K., Binger T., Eckerle I., Tschapka M., Zaki A.M., Osterhaus A.D., Fouchier R.A., Haagmans B.L., Drosten C. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio. 2012, 3.
131. Munster V.J., de W.E., Feldmann H. Pneumonia from human coronavirus in a macaque model. N. Engl. J. Med. 2013, 368:1560-1562.
132. Nishiura H., Ejima K., Mizumoto K. Missing information in animal surveillance of MERS-CoV. Lancet Infect. Dis. 2014, 14:100.
133. Nowotny N., Kolodziejek J. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013. Euro Surveill. 2014, 19.
134. Omrani A.S., Matin M.A., Haddad Q., Al-Nakhli D., Memish Z.A., Albarrak A.M. A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case. Int. J. Infect. Dis. 2013, 17:e668-e672.
135. Public Health and Animal Health Experts Review Knowledge on MERS-CoV. 8-8-2014f 2014, http://www.oie.int/en/for-the-media/press-releases/detail/article/public-health-and-animal-health-experts-review-knowledge-on-mers-cov/.
136. Payne D.C., Iblan I., Alqasrawi S., Al N.M., Rha B., Tohme R.A., Abedi G.R., Farag N.H., Haddadin A., Al S.T., Jarour N., Swerdlow D.L., Jamieson D.J., Pallansch M.A., Haynes L.M., Gerber S.I., Al Abdallat M.M. Stillbirth During Infection With Middle East Respiratory Syndrome Coronavirus. J. Infect. Dis. 2014.
137. Penttinen P.M., Kaasik-Aaslav K., Friaux A., Donachie A., Sudre B., Mato-Gauci A.J., Memish Z.A., Coulombier D. Taking stock of the first 133 MERS coronavirus cases globally - Is the epidemic changing?. Euro Surveill. 2013, 18.
138. Perera R.A., Wang P., Gomaa M.R., El-Shesheny R., Kandeil A., Bagato O., Siu L.Y., Shehata M.M., Kayed A.S., Moatasim Y., Li M., Poon L.L., Guan Y., Webby R.J., Ali M.A., Peiris J.S., Kayali G. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013, 18(ii).
139. Poletto C., Pelat C., Levy-Bruhl D., Yazdanpanah Y., Boelle P.-Y., Colizza V. Assessment of the MERS-CoV Epidemic Situation in the Middle East Region 2013.
140. Program for Monitoring Emerging Diseases ProMED Mail. 8-6-2014 2014, http://www.promedmail.org/.
141. ProMED Novel Coronavirus - Saudi Arabia: Human Isolate. 11-4-2012 2012, http://www.promedmail.org/direct.php?id=20120920.1302733.
142. ProMED Novel Coronavirus - Saudi Arabia: Human Isolate 2014, http://www.promedmail.org/direct.php?id=20120920.1302733.
143. Puzelli S., Azzi A., Santini M.G., Di M.A., Facchini M., Castrucci M.R., Meola M., Arvia R., Corcioli F., Pierucci F., Baretti S., Bartoloni A., Bartolozzi D., de M.M., Galli L., Pompa M.G., Rezza G., Balocchini E., Donatelli I. Investigation of an imported case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013. Euro Surveill. 2013, 18.
144. Raj V.S., Farag E.A.B.A., Reusken C.B.E.M., Lamers M.M., Pas S.D., Voermans J., Smits S.L., Osterhaus A.D.M.E., Al-Mawlawi N., Al-Romaihi H.E., AlHajri M.M., El-Sayed A.M., Mohran K.A., Ghobashy H., Alhajri F., Al-Thani M., Al-Marri S.A., El-Maghraby M.M., Koopmans M.P.G., Haagmans B.L. Isolation of MERS Coronavirus from a Dromedary Camel, Qatar, 2014. Emerg. Infect. Dis. 2014, 20.
145. Raj V.S., Mou H., Smits S.L., Dekkers D.H., Muller M.A., Dijkman R., Muth D., Demmers J.A., Zaki A., Fouchier R.A., Thiel V., Drosten C., Rottier P.J., Osterhaus A.D., Bosch B.J., Haagmans B.L. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 2013, 495:251-254.
146. Raj V.S., Osterhaus A.D., Fouchier R.A., Haagmans B.L. MERS: emergence of a novel human coronavirus. Curr. Opin. Virol. 2014, 5C:58-62.
147. Reusken C., Mou H., Godeke G.J., van der H.L., Meyer B., Muller M.A., Haagmans B., De S.R., Schuurman N., Dittmer U., Rottier P., Osterhaus A., Drosten C., Bosch B.J., Koopmans M. Specific serology for emerging human coronaviruses by protein microarray. Euro Surveill. 2013, 18:20441.
148. Reusken C.B., Ababneh M., Raj V.S., Meyer B., Eljarah A., Abutarbush S., Godeke G.J., Bestebroer T.M., Zutt I., Muller M.A., Bosch B.J., Rottier P.J., Osterhaus A.D., Drosten C., Haagmans B.L., Koopmans M.P. Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013. Euro Surveill. 2013, 18:20662.
149. Reusken C.B., Farag E.A., Jonges M., Godeke G.J., El-Sayed A.M., Pas S.D., Raj V.S., Mohran K.A., Moussa H.A., Ghobashy H., Alhajri F., Ibrahim A.K., Bosch B.J., Pasha S.K., Al-Romaihi H.E., Al-Thani M., Al-Marri S.A., AlHajri M.M., Haagmans B.L., Koopmans M.P. Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014. Euro Surveill. 2014, 19.
150. Reusken C.B., Haagmans B.L., Muller M.A., Gutierrez C., Godeke G.J., Meyer B., Muth D., Raj V.S., Smits-De V.L., Corman V.M., Drexler J.F., Smits S.L., El Tahir Y.E., De S.R., van B.J., Nowotny N., van M.K., Hidalgo-Hermoso E., Bosch B.J., Rottier P., Osterhaus A., Gortazar-Schmidt C., Drosten C., Koopmans M.P. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect. Dis. 2013, 13:859-866.
151. Reusken C.B.E.M., Messadi L., Feyisa A., Ularamu H., Godeke G.J., Danmarwa A., Dawo F., Jemli M., Melaku S., Shamaki D., Woma Y., Wungak Y., Gebremedhin E.Z., Zutt I., Bosch B.J., Haagmans B.L., Koopmans M.P.G. Geographic distribution of MERS Coronavirus among dromedary camels, Africa. Emerg. Infect. Dis. 2014, 20.
152. Reuss A., Litterst A., Drosten C., Seilmaier M., Bohmer M., Graf P., Gold H., Wendtner C.M., Zanuzdana A., Schaade L., Haas W., Buchholz U. Contact investigation for imported case of Middle East respiratory syndrome, Germany. Emerg. Infect. Dis. 2014, 20:620-625.
153. Reuters Saudi Arabia Replaces Health Minister Amid MERS Virus Fears 2014, http://www.reuters.com/article/2014/04/21/us-saudi-minister-mers-idUSBREA3K0QI20140421.
154. Soaring MERS Cases Cause Pandemic Jitters, but Causes are Unclear 2014, http://news.sciencemag.org/health/2014/04/soaring-mers-cases-cause-pandemic-jitters-causes-are-unclear.
155. Sabat R. IL-10 family of cytokines. Cytokine Growth Factor Rev. 2010, 21:315-324.
156. Salathe M., Freifeld C.C., Mekaru S.R., Tomasulo A.F., Brownstein J.S. Influenza A (H7N9) and the importance of digital epidemiology. N. Engl. J. Med. 2013, 369:401-404.
157. Sampathkumar P. Middle East respiratory syndrome: what clinicians need to know. Mayo Clin. Proc. 2014, 89:1153-1158.
158. Sciencemag As Outbreak Continues, Confusion Reigns Over Virus Patents 2014, http://news.sciencemag.org/people-events/2013/05/outbreak-continues-confusion-reigns-over-virus-patents.
159. Sharmin R., Islam A.B. A highly conserved WDYPKCDRA epitope in the RNA directed RNA polymerase of human coronaviruses can be used as epitope-based universal vaccine design. BMC Bioinformatics 2014, 15:161.
160. Shi Z. Emerging infectious diseases associated with bat viruses. Sci. China Life Sci. 2013, 56:678-682.
161. SILVER consortium SILVER MERS-Coronavirus Outbreak Pipeline. 22-1-2015 2015, http://www.silver-europe.com/spip.php?article229.
162. Smith I., Wang L.F. Bats and their virome: an important source of emerging viruses capable of infecting humans. Curr. Opin. Virol. 2013, 3:84-91.
163. Smits S.L., Raj V.S., Pas S.D., Reusken C.B.E.M., Mohran K., Farag E.A.B.A., Al-Romaihi H.E., AlHajri M.M., Haagmans B.L., Koopmans M.P. Reliable typing of MERS-CoV variants with a small genome fragment. J. Clin. Virol. 2015.
164. Spanakis N., Tsiodras S., Haagmans B.L., Raj V.S., Pontikis K., Koutsoukou A., Koulouris N.G., Osterhaus A.D., Koopmans M.P., Tsakris A. Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen. Int. J. Antimicrob. Agents 2014, 44:528-532.
165. Tang X.C., Agnihothram S.S., Jiao Y., Stanhope J., Graham R.L., Peterson E.C., Avnir Y., Tallarico A.S., Sheehan J., Zhu Q., Baric R.S., Marasco W.A. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution. Proc. Natl. Acad. Sci. U. S. A. 2014.
166. The WHO MERS-CoV Research Group State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans. PLoS Curr. Ed. 2013, 1.
167. Tsiodras S., Baka A., Mentis A., Iliopoulos D., Dedoukou X., Papamavrou G., Karadima S., Emmanouil M., Kossyvakis A., Spanakis N., Pavli A., Maltezou H., Karageorgou A., Spala G., Pitiriga V., Kosmas E., Tsiagklis S., Gkatzias S., Koulouris N., Koutsoukou A., Bakakos P., Markozanhs E., Dionellis G., Pontikis K., Rovina N., Kyriakopoulou M., Efstathiou P., Papadimitriou T., Kremastinou J., Tsakris A., Saroglou G. A case of imported Middle East Respiratory Syndrome coronavirus infection and public health response, Greece, April 2014. Euro Surveill. 2014, 19.
168. van Boheemen S., de Graaf M., Lauber C., Bestebroer T.M., Raj V.S., Zaki A.M., Osterhaus A.D., Haagmans B.L., Gorbalenya A.E., Snijder E.J., Fouchier R.A. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio. 2012, 3.
169. van Doremalen N., Bushmaker T., Munster V.J. Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill. 2013, 18.
170. van Doremalen N., Miazgowicz K.L., Milne-Price S., Bushmaker T., Robertson S., Scott D., Kinne J., McLellan J.S., Zhu J., Munster V.J. Host Species Restriction of Middle East Respiratory Syndrome Coronavirus through its Receptor Dipeptidyl Peptidase 4. J. Virol. 2014.
171. Wang N., Shi X., Jiang L., Zhang S., Wang D., Tong P., Guo D., Fu L., Cui Y., Liu X., Arledge K.C., Chen Y.H., Zhang L., Wang X. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res. 2013, 23:986-993.
172. Woo P.C., Lau S.K., Huang Y., Yuen K.Y. Coronavirus diversity, phylogeny and interspecies jumping. Exp. Biol. Med. (Maywood) 2009, 234:1117-1127.
173. World Health Organization Infection Prevention and Control During Health Care for Probable or Confirmed Cases of Novel Coronavirus (nCoV) infection. 5-6-2013a 2013, http://www.who.int/csr/disease/coronavirus_infections/IPCnCoVguidance:06May13.pdf.
174. World Health Organization Laboratory Testing for Middle East Respiratory Syndrome Coronavirus. 16-9-2013b 2013, http://who.int/csr/disease/coronavirus_infections/MERS_Lab_recos_16_Sept_2013.pdf?ua=1.
175. World Health Organization Case Definition for Case Finding Severe Respiratory Disease Associated with Novel Coronavirus: Interim Case Definition as of 25 September 2012. 12-5-2014 2014, http://www.who.int/csr/disease/coronavirus_infections/case_definition_25_09_2012/en/.
176. World Health Organization Global Alert and Response (GAR): Coronavirus Infections 2014, http://www.who.int/csr/don/archive/disease/coronavirus_infections/en/.
177. World Health Organization Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Summary and Literature Update-as of 9 May 2014. 5-9-2014c 2014, http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_Update_09_May_2014.pdf?ua=1.
178. World Health Organization Revised Interim Case Definition for Reporting to WHO - Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Interim Case Definition as of July 2013. 12-5-2014 2014, http://www.who.int/csr/disease/coronavirus_infections/case_definition/en/.
179. World Health Organization WHO Risk Assessment Middle East Respiratory Syndrome Coronavirus (MERS-CoV). 24-4-2014e 2014, http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_RA_20140424.pdf?ua=1.
180. World Health Organization WHO Statement on the Fifth Meeting of the IHR Emergency Committee Concerning MERS-CoV: WHO Statement 2014, http://www.who.int/mediacentre/news/statements/2014/mers-20140514/en/.
181. Yao Y., Bao L., Deng W., Xu L., Li F., Lv Q., Yu P., Chen T., Xu Y., Zhu H., Yuan J., Gu S., Wei Q., Chen H., Yuen K.Y., Qin C. An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus. J. Infect. Dis. 2014, 209:236-242.
182. Zaki A.M., van B.S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012, 367:1814-1820.
183. Zhao G., Du L., Ma C., Li Y., Li L., Poon V.K., Wang L., Yu F., Zheng B.J., Jiang S., Zhou Y. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virol. J. 2013, 10:266.
184. Zhao J., Li K., Wohlford-Lenane C., Agnihothram S.S., Fett C., Zhao J., Gale M.J., Baric R.S., Enjuanes L., Gallagher T., McCray P.B., Perlman S. Rapid generation of a mouse model for Middle East respiratory syndrome. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:4970-4975.
185. Zhou J., Chu H., Li C., Wong B.H., Cheng Z.S., Poon V.K., Sun T., Lau C.C., Wong K.K., Chan J.Y., Chan J.F., To K.K., Chan K.H., Zheng B.J., Yuen K.Y. Active replication of middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J. Infect. Dis. 2014, 209:1331-1342.
186. Zielecki F., Weber M., Eickmann M., Spiegelberg L., Zaki A.M., Matrosovich M., Becker S., Weber F. Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J. Virol. 2013, 87:5300-5304.
187. Zumla A., Hui D.S. Infection control and MERS-CoV in health workers. Lancet 2014, 383:1869-1871.
188. Zumla A.I., Memish Z.A. Middle East respiratory syndrome coronavirus: epidemic potential or a storm in a teacup?. Eur. Respir. J. 2014, 43:1243-1248.